[Use of ambroxol in the therapy of neonatal respiratory insufficiency].
作者信息
Colombo M L, Dogliani P, Ulla L
出版信息
Minerva Pediatr. 1988 Jun;40(6):333-8.
PMID:3185433
Abstract
摘要
相似文献
1
[Use of ambroxol in the therapy of neonatal respiratory insufficiency].
Minerva Pediatr. 1988 Jun;40(6):333-8.
2
[Effect of Lasolvan on the course of respiratory distress syndrome in newborn infants].
Pediatr Pol. 1987 Jun;62(6):382-7.
3
The pharmacology of ambroxol--review and new results.
Eur J Respir Dis Suppl. 1987;153:255-62.
4
[RDS prevention by prednilyden and ambroxol. A comparative study].
Arch Gynecol. 1979 Jul 20;228(1-4):204.
5
6
Ambroxol in the treatment of idiopathic respiratory distress syndrome. An interim report on a controlled double-blind multicenter study versus placebo.
Respiration. 1987;51 Suppl 1:60-7. doi: 10.1159/000195276.
7
[Ambroxol versus betamethasone for stimulating antepartal lung maturity--a multicenter study].
Z Geburtshilfe Perinatol. 1986 Feb-Mar;190(1):49-59.
8
Cord blood prolactin and thyroid hormone levels after antenatal administration of betamethasone or ambroxol for prevention of respiratory distress syndrome (RDS).
Biol Res Pregnancy Perinatol. 1984;5(3):124-9.
9
Polymorphonuclear leucocytes functions from premature infants after prevention of respiratory distress syndrome with betamethasone and ambroxol.
Biol Res Pregnancy Perinatol. 1984;5(3):130-4.
10
[Ambroxol in the treatment of idiopathic respiratory distress syndrome].
Cesk Pediatr. 1992 Jul;47(7):421-3.
Zotero 插件